Characteristics of invasive pneumococcal disease (IPD) caused by emerging serotypes after the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) in England; prospective observational cohort study, 2014-18.,Clinical Infectious Diseases

当前位置： X-MOL 学术 › Clin. Infect. Dis. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Characteristics of invasive pneumococcal disease (IPD) caused by emerging serotypes after the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) in England; prospective observational cohort study, 2014-18.
Clinical Infectious Diseases ( IF 11.8 ) Pub Date : 2020-02-25 , DOI: 10.1093/cid/ciaa043
Zahin Amin-Chowdhury ₁ , Sarah Collins ₁ , Carmen Sheppard ₂ , David Litt ₂ , Norman K Fry ₁ , Nick Andrews ₃ , Shamez N Ladhani _{1,

4}

Affiliation

England is experiencing a rapid increase in invasive pneumococcal disease (IPD) caused by serotypes 8, 12F, and 9N; their clinical characteristics and outcomes have not been described.

中文翻译：